No Data
No Data
Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of Its AI-Driven DeepView System
Spectral AI Expands Patent Portfolio, Bolstering AI-driven Wound Care Platform | NASDAQ:MDAI
Express News | Spectral AI Adds Three New Clinical Trial Sites to Expedite Emergency Department Patient Enrollment
Spectral AI Adds Three New Clinical Sites to Pivotal Burn Study | NASDAQ:MDAI
H.C. Wainwright Initiates Spectral AI(MDAI.US) With Buy Rating, Announces Target Price $3.5
Buy Rating on Spectral AI: Innovative AI-Driven Wound Care Poised for Market Disruption
No Data